BUD pre-treatment of MDMs from COPD-ES counteracted the bacterial reductions in receptor expression for both SP (SR-AI) and NTHI (CD206), and approached statistical significance for neutralizing NTHI reductions of MARCO. This evidence concerns the gene MRC1 and chronic obstructive pulmonary disease.